CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
about
A new therapeutic option for postoperative pain management with oxycodone HCI injectionNeuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future ProspectsGenetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients.Perspectives on Intravenous Oxycodone for Control of Postoperative Pain.Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.SCAMPs for Multimodal Post-Operative Analgesia: A Concept to Standardize and Individualize Care.Codeine and opioid metabolism: implications and alternatives for pediatric pain management.Review of Opioid Pharmacogenetics and Considerations for Pain Management.Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model.The pharmacogenetics of medications used in general anesthesia.Population pharmacokinetics and analgesic potency of oxycodone.Value of Supportive Care Pharmacogenomics in Oncology Practice.
P2860
Q26747676-CE9D2D7C-9248-4BF8-803F-FF8ADAE049F1Q26799409-709860F6-8344-4D01-B25A-9B3857259864Q33833207-C082BBD7-21B0-47DA-BF00-ED5D79A0FD76Q34046633-E61EF0F7-74D1-4178-B141-69EB908D7F12Q38590899-49662340-F214-4DAC-86F7-D448FA911960Q38614128-9D318DF4-D6CC-4D3E-859C-82F11F36696AQ38731079-8FC32169-8746-47F8-BD5F-3BC958030CCBQ38985139-FA154BDF-CF9A-4A83-AF87-19C8C2D553D9Q39190293-5C04B22B-1F9D-4979-93C5-B33CCA97E6E3Q39430407-A91C12B1-540D-40F2-81A1-82F3F54CF391Q41678423-C858BDCF-A434-43BB-87D3-F3D33086AEA9Q47213395-A67007F2-9BB4-4B78-9AA6-D383DF8D3CEEQ47395038-8C675F13-2B80-4D99-8CE6-C273834216A4Q52603826-30EC91A9-E1EE-4D58-BB02-12785AD63F89
P2860
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@ast
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@en
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@nl
type
label
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@ast
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@en
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@nl
prefLabel
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@ast
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@en
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@nl
P2093
P2860
P1433
P1476
CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
@en
P2093
Frank Stuber
Lutz E Lehmann
Malte Book
Ulrike M Stamer
P2860
P304
P356
10.1371/JOURNAL.PONE.0060239
P407
P577
2013-03-28T00:00:00Z